Literature DB >> 31078609

Brodalumab in the treatment of moderate to severe psoriasis in patients when previous anti-interleukin 17A therapies have failed.

Grace Kimmel1, Margot Chima2, Hee Jin Kim2, Jennifer Bares2, Christopher J Yao2, Giselle Singer2, Soo Jung Kim3, Jerry Bagel4, Mark Lebwohl2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31078609     DOI： 10.1016/j.jaad.2019.05.007

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  9 in total

Review 1.  Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.

Authors:  Alan Menter; Tina Bhutani; Benjamin Ehst; Boni Elewski; Abby Jacobson
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-07

2.  Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.

Authors:  Eleftheria Tampouratzi; Theodora Kanni; John Katsantonis; Theodora Douvali
Journal:  F1000Res       Date:  2019-11-26

Review 3.  The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.

Authors:  Taoming Liu; Sheng Li; Shuni Ying; Shunli Tang; Yuwei Ding; Yali Li; Jianjun Qiao; Hong Fang
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

Review 4.  The Role of Helper T Cells in Psoriasis.

Authors:  Peng Hu; Mengyao Wang; Hu Gao; Ai Zheng; Jinhui Li; Dezhi Mu; Jiyu Tong
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

5.  Cytokine RNA In Situ Hybridization Permits Individualized Molecular Phenotyping in Biopsies of Psoriasis and Atopic Dermatitis.

Authors:  Alice Wang; Alexander L Fogel; Michael J Murphy; Gauri Panse; Meaghan K McGeary; Jennifer M McNiff; Marcus Bosenberg; Matthew D Vesely; Jeffrey M Cohen; Christine J Ko; Brett A King; William Damsky
Journal:  JID Innov       Date:  2021-05-07

6.  Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison.

Authors:  Philip Hampton; Emma Borg; Jes Birger Hansen; Matthias Augustin
Journal:  Psoriasis (Auckl)       Date:  2021-11-03

7.  Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1).

Authors:  J L W Lambert; S Segaert; P D Ghislain; T Hillary; A Nikkels; F Willaert; J Lambert; R Speeckaert
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-08       Impact factor: 6.166

Review 8.  Biologic Treatments of Psoriasis: An Update for the Clinician.

Authors:  Nicholas D Brownstone; Julie Hong; Megan Mosca; Edward Hadeler; Wilson Liao; Tina Bhutani; John Koo
Journal:  Biologics       Date:  2021-02-16

9.  Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways.

Authors:  M A X Tollenaere; J Hebsgaard; D A Ewald; P Lovato; S Garcet; X Li; S D Pilger; M L Tiirikainen; M Bertelsen; J G Krueger; H Norsgaard
Journal:  Br J Dermatol       Date:  2021-05-31       Impact factor: 9.302
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.